Swedish Orphan Biovitrum

Swedish Orphan Biovitrum ABTypePublicTraded asNasdaq Stockholm: SOBIIndustryPharmaceuticalHeadquartersStockholm, SwedenKey peopleGuido Oelkers (President and CEO)ProductsTreatments in the areas of haematology, immunology and specialty careRevenueSEK 15.261 billion (2020)Number of employees1,509ParentInvestor...